Two hospital-based doctors call on FDA to clear OTC hearing aids using the 510(k) pathway.
FDA clears a CorticoMetrics 510(k) for Thinq, its artificial intelligence-based software for use by radiologists and neurologists to provide quantitat...
FDA approves an Eiger BioPharmaceuticals NDA for Zokinvy (lonafarnib) for treating Hutchinson-Gilford Progeria Syndrome and processing-deficient Proge...
FDA publishes a guidance for using bioburden reduction systems with dry heat to reuse certain filtering facepiece respirators.
FDA defers its review decision on a Revance Therapeutics BLA for daxibotulinumtoxinA for injection, an investigational neuromodulator for treating mod...
Purdue Pharma pleads guilty to three felony counts as part of a plea agreement announced in October.
Merck submits a BLA for V114, an investigational 15-valent pneumococcal conjugate vaccine for use in adults 18 years of age and older.
Three Covington & Burling attorneys analyze how a Biden administration may make its mark on FDA Centers and programs.